Drugs Resistance in Heart Diseases

[1]  J. Padovan,et al.  Three Generations of β-blockers: History, Class Differences and Clinical Applicability. , 2019, Current hypertension reviews.

[2]  Takashi Ito,et al.  Uric acid enhances alteplase-mediated thrombolysis as an antioxidant , 2018, Scientific Reports.

[3]  Ashkan Karimi,et al.  Thiazide Therapy in Chronic Kidney Disease: Renal and Extra Renal Targets. , 2018, Current drug metabolism.

[4]  J. Ambrose,et al.  Understanding myocardial infarction , 2018, F1000Research.

[5]  G. Lip,et al.  Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[6]  U. Alon.  The Effects of Diuretics on Mineral and Bone Metabolism. , 2018, Pediatric endocrinology reviews : PER.

[7]  F. Fernández‐Avilés,et al.  Impact of age and sex on survival and causes of death in adults with congenital heart disease. , 2017, International journal of cardiology.

[8]  O. Ziff,et al.  Digoxin: The good and the bad. , 2016, Trends in cardiovascular medicine.

[9]  L. Wilkins.  2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals , 2016, Journal of the American Heart Association.

[10]  A. Šukalo,et al.  Treatment of Hypertension with Combination of Lisinopril/Hydrochlorothiazide , 2016, Medical archives.

[11]  Nora Macleod-Glover,et al.  Digoxin toxicity: Case for retiring its use in elderly patients? , 2016, Canadian family physician Medecin de famille canadien.

[12]  I. Asher,et al.  Angiotensin-converting enzyme inhibitor-induced angioedema. , 2015, The American journal of medicine.

[13]  P. Nanasi,et al.  The Janus face of adenosine: antiarrhythmic and proarrhythmic actions. , 2014, Current pharmaceutical design.

[14]  R. Khatib,et al.  Pharmacology of Medications Used in the Treatment of Atherosclerotic Cardiovascular Disease , 2014 .

[15]  J. Hallas,et al.  Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. , 2013, The American journal of medicine.

[16]  R. Schwinger,et al.  Cardio-selective beta-blocker: pharmacological evidence and their influence on exercise capacity. , 2013, Cardiovascular therapeutics.

[17]  B. Funke,et al.  Dilated cardiomyopathy , 2007, Archives of Disease in Childhood.

[18]  B. Dong,et al.  Long-term beta blockers for stable angina: systematic review and meta-analysis , 2012, European Journal of Preventive Cardiology.

[19]  P. Rao.  Congenital Heart Disease - Selected Aspects , 2012 .

[20]  G. Ellrodt,et al.  Verapamil: A Review of its Pharmacological Properties and Therapeutic Use , 1978, Drugs.

[21]  K. Vrana,et al.  Elsevier's integrated review pharmacology , 2012 .

[22]  Julio C. B. Ferreira,et al.  Nitroglycerin use in myocardial infarction patients. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[23]  J. Rush,et al.  Safety Profiles of the Angiotensin-Converting Enzyme Inhibitors , 2012, Drugs.

[24]  W. Cushman,et al.  Thiazide and Loop Diuretics , 2011, Journal of clinical hypertension.

[25]  A. Fares.  Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients , 2011, Journal of cardiovascular disease research.

[26]  N. Dhalla,et al.  β-adrenergic blockade attenuates cardiac dysfunction and myofibrillar remodelling in congestive heart failure , 2010, Journal of cellular and molecular medicine.

[27]  T. K. Agasti,et al.  Textbook of anaesthesia for postgraduates , 2011 .

[28]  Jason L Salemi,et al.  Mortality Resulting From Congenital Heart Disease Among Children and Adults in the United States, 1999 to 2006 , 2010, Circulation.

[29]  H. Vandekerckhove,et al.  Beta-blockers: focus on mechanism of action Which beta-blocker, when and why? , 2010, Acta cardiologica.

[30]  N. Dhalla,et al.  Mechanisms of the beneficial effects of beta-adrenoceptor antagonists in congestive heart failure. , 2010, Experimental and clinical cardiology.

[31]  M. Diplomate,et al.  8. Cardiovascular System , 2009 .

[32]  D. Ellison,et al.  Thiazide Effects and Adverse Effects: Insights From Molecular Genetics , 2009, Hypertension.

[33]  M. Weir.  β-Blockers in the Treatment of Hypertension: Are There Clinically Relevant Differences? , 2009, Postgraduate medicine.

[34]  Felix Yang,et al.  Quinidine revisited. , 2009, The American journal of medicine.

[35]  Matthew J Strickland,et al.  Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. , 2008, The Journal of pediatrics.

[36]  J. Cruickshank.  Initial management of cardiac arrhythmias. , 2008, Australian family physician.

[37]  S. Gordon,et al.  Drugs used in the management of heart disease and cardiac arrhythmias , 2008 .

[38]  S. Bozkurt,et al.  Cardiovascular toxicity due to metoprolol poisoning in a patient with coronary artery disease. , 2007, British journal of clinical pharmacology.

[39]  G. Gamba,et al.  Thiazide diuretics directly induce osteoblast differentiation and mineralized nodule formation by interacting with a sodium chloride co-transporter in bone. , 2007, Journal of the American Society of Nephrology.

[40]  Jeffrey A. Feinstein,et al.  Noninherited Risk Factors and Congenital Cardiovascular Defects: Current Knowledge: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young , 2007, Circulation.

[41]  P. Palatini,et al.  Autonomic nervous system function in chronic hypotension associated with Bartter and Gitelman syndromes. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[42]  G. Hankey,et al.  Aspirin resistance , 2006, The Lancet.

[43]  M. Ritter,et al.  Thiazide-sensitive NaCl-cotransporter in the Intestine , 2005, Journal of Biological Chemistry.

[44]  K. Swedberg,et al.  [Expert Consensus document on beta-adrenergic receptor blockers]. , 2004, Revista espanola de cardiologia.

[45]  A. Hughes,et al.  How do thiazide and thiazide-like diuretics lower blood pressure? , 2004, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[46]  C. January,et al.  Biology of cardiac arrhythmias: ion channel protein trafficking. , 2004, Circulation research.

[47]  G. A. West,et al.  Sinus slowing and pacemaker shift caused by adenosine in rabbit SA node , 2004, Pflügers Archiv.

[48]  R. Macallister,et al.  Vascular natriuretic peptide receptor‐linked particulate guanylate cyclases are modulated by nitric oxide–cyclic GMP signalling , 2003, British journal of pharmacology.

[49]  D. Grobbee,et al.  Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials , 2003, Journal of Human Hypertension.

[50]  J. Vane,et al.  The mechanism of action of aspirin. , 2003, Thrombosis research.

[51]  C. Billington,et al.  Signaling and regulation of G protein-coupled receptors in airway smooth muscle , 2003, Respiratory research.

[52]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[53]  J. Stamler,et al.  Identification of the enzymatic mechanism of nitroglycerin bioactivation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[54]  A. Semplicini,et al.  Reduced content of alpha subunit of Gq protein content in monocytes of Bartter and Gitelman syndromes: relationship with vascular hyporeactivity. , 2002, Kidney international.

[55]  L. P. Van den Heuvel,et al.  Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes. , 2001, Kidney international.

[56]  R. Lifton,et al.  Mutations in the Na-Cl Cotransporter Reduce Blood Pressure in Humans , 2001, Hypertension.

[57]  S. Tenreiro,et al.  Resistance and Adaptation to Quinidine in Saccharomyces cerevisiae: Role of QDR1 (YIL120w), Encoding a Plasma Membrane Transporter of the Major Facilitator Superfamily Required for Multidrug Resistance , 2001, Antimicrobial Agents and Chemotherapy.

[58]  G. Lip,et al.  ABC of hypertension: The pathophysiology of hypertension. , 2001, BMJ.

[59]  J D Erickson,et al.  Racial and temporal variations in the prevalence of heart defects. , 2001, Pediatrics.

[60]  J. Horowitz,et al.  Nitroglycerin Tolerance in Human Vessels: Evidence for Impaired Nitroglycerin Bioconversion , 2000, Circulation.

[61]  D M Roden,et al.  Antiarrhythmic drugs: from mechanisms to clinical practice , 2000, Heart.

[62]  A. Semplicini,et al.  Control of Vascular Tone in the Syndromes of Bartter and Gitelman , 2000, Critical reviews in clinical laboratory sciences.

[63]  P. A. Friedman,et al.  Diuretic effects on calcium metabolism. , 1999, Seminars in nephrology.

[64]  G. Desir,et al.  Defective processing and expression of thiazide-sensitive Na-Cl cotransporter as a cause of Gitelman's syndrome. , 1999, American journal of physiology. Renal physiology.

[65]  A. Hughes,et al.  Inhibition of carbonic anhydrase accounts for the direct vascular effects of hydrochlorothiazide. , 1999, Hypertension.

[66]  G. Desir,et al.  Defective processing and expression of thiazide-sensitive Na-Cl cotransporter as a cause of Gitelman's syndrome. , 1999, The American journal of physiology.

[67]  A. Hughes,et al.  Thiazide-induced vasodilation in humans is mediated by potassium channel activation. , 1998, Hypertension.

[68]  A. Quyyumi,et al.  Aspirin improves endothelial dysfunction in atherosclerosis. , 1998, Circulation.

[69]  B. Lerman,et al.  Adenosine and Cardiac Arrhythmias , 1998 .

[70]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[71]  M. Hartog,et al.  Aspirin protects low density lipoprotein from oxidative modification. , 1997, Heart.

[72]  Bang-Hun Lee.  Treatment of Hypertension: Drug Therapy , 1997 .

[73]  T. Paul,et al.  Adenosine: An Effective and Safe Antiarrhythmic Drug in Pediatrics , 1997, Pediatric Cardiology.

[74]  A. D'Angelo,et al.  Increased urinary NO2-/NO3- and cyclic guanosine monophosphate levels in patients with Bartter's syndrome: relationship to vascular reactivity. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[75]  R. Lifton,et al.  Gitelman's variant of Barter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na–Cl cotransporter , 1996, Nature Genetics.

[76]  R Reilly,et al.  Expression of the thiazide-sensitive Na-Cl cotransporter in rat and human kidney. , 1995, The American journal of physiology.

[77]  H. Velázquez,et al.  Expression of the thiazide-sensitive Na-Cl cotransporter by rabbit distal convoluted tubule cells. , 1995, The Journal of clinical investigation.

[78]  R. Ferner,et al.  Poisoning with anti-hypertensive drugs: angiotensin converting enzyme inhibitors. , 1995, Journal of human hypertension.

[79]  P. Pickkers,et al.  Relaxation and decrease in [Ca2+]i by hydrochlorothiazide in guinea‐pig isolated mesenteric arteries , 1995, British journal of pharmacology.

[80]  W. S. Lee,et al.  Molecular cloning, primary structure, and characterization of two members of the mammalian electroneutral sodium-(potassium)-chloride cotransporter family expressed in kidney. , 1994, The Journal of biological chemistry.

[81]  J. Reid,et al.  Blood pressure response to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure. , 1993, The American journal of cardiology.

[82]  Y. Friedlander,et al.  Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. , 1993, Chest.

[83]  A. Camm,et al.  Adenosine and cardiac arrhythmias. , 1992, BMJ.

[84]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.

[85]  R. N. Brogden,et al.  Atenolol , 1991, Drugs.

[86]  D. Ellison.  The physiologic basis of diuretic synergism: its role in treating diuretic resistance. , 1991, Annals of internal medicine.

[87]  K. Seibert,et al.  Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. , 1990, The Journal of clinical investigation.

[88]  U. Borchard,et al.  Classification and action of antiarrhythmic drugs. , 1989, European heart journal.

[89]  C. Isles,et al.  Profound hypotension after atenolol in severe hypertension. , 1989, BMJ.

[90]  F. S. Wright,et al.  Adaptation of the distal convoluted tubule of the rat. Structural and functional effects of dietary salt intake and chronic diuretic infusion. , 1989, The Journal of clinical investigation.

[91]  N. Arber.  Delirium induced by atenolol. , 1988, BMJ.

[92]  P. Friedman.  Biochemistry and pharmacology of diuretics. , 1988, Seminars in nephrology.

[93]  V. Nerme,et al.  The beta 1- and beta 2-adrenoceptor affinity of atenolol and metoprolol. A receptor-binding study performed with different radioligands in tissues from the rat, the guinea pig and man. , 1988, Biochemical pharmacology.

[94]  J. M. Optiz,et al.  Update on counseling the family with a first-degree relative with a congenital heart defect. , 1988, American journal of medical genetics.

[95]  F. S. Wright,et al.  Thiazide-sensitive sodium chloride cotransport in early distal tubule. , 1987, The American journal of physiology.

[96]  S. Rahimtoola,et al.  Changes in blood rheology in patients with stable angina pectoris as a result of coronary artery disease. , 1987, Circulation.

[97]  L. Belardinelli,et al.  Effect of Adenosine on Atrioventricular Conduction. I: Site and Characterization of Adenosine Action in the Guinea Pig Atrioventricular Node , 1986, Circulation research.

[98]  F. S. Wright,et al.  Effects of diuretic drugs on Na, Cl, and K transport by rat renal distal tubule. , 1986, The American journal of physiology.

[99]  J. Vohra.  Verapamil in cardiac arrhythmias: an overview. , 1982, Clinical and experimental pharmacology & physiology. Supplement.

[100]  A. Yacobi,et al.  Nitroglycerin pharmacokinetics after intravenous infusion in normal subjects. , 1981, Journal of pharmaceutical sciences.

[101]  Bridget Wilcken,et al.  Pathogenesis of coronary artery disease , 1969 .

[102]  R. Jennings,et al.  Structural Changes in Myocardium During Acute Ischemia , 1974, Circulation research.

[103]  J. Vane,et al.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. , 1971, Nature: New biology.

[104]  L. Resnekov.  Cardiac Arrhythmias , 1964, Postgraduate medical journal.